Finnish Inion has today announced that it has signed a cooperation and research agreement with Angiomed, a subsidiary of the life science products group, C.R. Bard Inc. Angiomed will pay for the feasibility phase of this project in the form of upfront and milestone payments. If the feasibility study is successful, it could lead to a longer term development and/or manufacturing agreement.
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater